Cockroach-derived medicine is real, commercially produced, and backed by a growing body of clinical research. The most widely used product is Kangfuxin liquid, an extract made from the American cockroach (Periplaneta americana) that has been used in Chinese hospitals for decades to treat wounds, ulcers, and damaged mucous membranes. While the idea sounds unusual, the science behind it reveals why these insects caught the attention of researchers in the first place.
What Cockroach Medicine Actually Is
Kangfuxin liquid is an ethanol-based extract produced from farmed American cockroaches. The cockroaches are dried at high temperatures (80 to 90°C), ground into a fine powder, then soaked in ethanol and filtered. This process is repeated multiple times to concentrate the active compounds. The final product contains a mix of small proteins (polypeptides), amino acids, nucleosides, and alkaloids.
This isn’t a folk remedy cobbled together in someone’s kitchen. The cockroaches are sourced from supply chains that follow Good Agricultural Practice standards, with strict screening for heavy metals and harmful microorganisms. Testing of processed cockroach material shows mercury levels far below safety limits, no detectable arsenic, cadmium, or chromium, and virtually no mold. Salmonella testing comes back negative. The finished product is sealed in moisture-resistant packaging and stored under controlled conditions.
How It Promotes Healing
The extract works primarily by activating a cellular signaling pathway that tells skin cells to multiply and migrate toward a wound. In mouse models, treatment with the extract significantly increased levels of proteins involved in this pathway within skin cells called keratinocytes, the cells that form your skin’s outer barrier.
Beyond stimulating skin cell growth, the extract triggers several other repair mechanisms simultaneously. Gene analysis shows it ramps up the activity of genes involved in forming new blood vessels, which is critical for delivering oxygen and nutrients to damaged tissue. It also boosts the production of a growth factor that helps blood vessel formation and upregulates glutamine levels, which feeds the rapidly dividing cells (fibroblasts, mucosal cells) that rebuild tissue. Some research suggests the extract can regulate the release of a signaling molecule that promotes wound closure while minimizing scar formation.
Clinical Uses and Evidence
The strongest clinical evidence for cockroach medicine comes from treating oral mucositis, the painful mouth sores that develop during chemotherapy. A meta-analysis of 21 randomized controlled trials involving 1,825 patients found that Kangfuxin liquid cut the rate of chemotherapy-induced mouth sores nearly in half compared to basic oral care alone. For severe cases, the incidence dropped even more dramatically. Patients using the extract also healed faster, with healing time reduced by roughly two and a half days on average.
One important caveat: when researchers compared Kangfuxin to other established medications for the same condition, the results were essentially identical. The extract performed as well as other drugs but not better. This positions it as a viable alternative rather than a superior treatment, which is still meaningful given that it offers a different mechanism of action and may suit patients who don’t tolerate conventional options.
In Chinese medical practice, the extract is also used for gastric ulcers, skin wounds, and burns, though the clinical trial data for these applications is less extensive than for oral mucositis. The wound-healing research, while promising, has been conducted primarily in animal models and laboratory settings.
Antimicrobial Properties
Separate from the commercial extract, researchers have investigated antimicrobial compounds found in cockroach tissues, particularly the brain and nervous system. Laboratory tests found that crude extracts from cockroach brains killed more than 90% of MRSA (methicillin-resistant Staphylococcus aureus) and a dangerous strain of E. coli within two hours. MRSA is notoriously difficult to treat with conventional antibiotics, so any new source of antimicrobial compounds attracts significant interest.
These antimicrobial findings are still at the laboratory stage. No one is prescribing cockroach brain extract for infections. But the discovery helps explain why cockroaches themselves rarely succumb to bacterial infections despite living in environments teeming with pathogens, and it points to a potential reservoir of novel antimicrobial molecules.
Safety Profile
The commercial extract appears to be well tolerated. In clinical settings, including use alongside aggressive treatments like stem cell transplants for multiple myeloma, no adverse reactions related to the heart, liver, kidneys, or blood clotting system were reported. The treatment also did not interfere with the effectiveness of patients’ primary disease treatments.
That said, the vast majority of clinical data comes from Chinese hospitals and research institutions. Kangfuxin liquid is not approved by the FDA or European regulatory agencies, and Western clinical trials are limited. Allergic reactions remain a theoretical concern for anyone with insect allergies, though they have not been prominently reported in the existing literature.
Where Cockroach Medicine Stands Today
Cockroach medicine occupies an unusual space: it sounds like pseudoscience but has real clinical data behind it, particularly for chemotherapy-related mouth sores and wound healing. The biological mechanisms are well characterized, the manufacturing process is standardized, and the safety profile in published studies is clean. At the same time, its use remains concentrated in China, where it has been part of the pharmaceutical landscape for years. Outside that context, it remains largely unknown and unavailable, a treatment with genuine potential that hasn’t yet crossed over into global medical practice.